Current evidence for the use of sugammadex in children

JD Tobias - Pediatric Anesthesia, 2017 - Wiley Online Library
Sugammadex is a novel pharmacologic agent, which reverses neuromuscular blockade with
a mechanism that differs from the commonly used, acetylcholinesterase inhibitors. Although …

The safety and efficacy of sugammadex for reversing neuromuscular blockade in younger children and infants

A Wang, A Tsivitis, S Ma, Z Jin, E Al Bizri… - Expert Opinion on Drug …, 2024 - Taylor & Francis
Introduction Sugammadex, a novel selective antagonist of non-depolarizing neuromuscular
blocking agents, has been shown to rapidly and effectively reverse moderate and deep …

Rocuronium versus suxamethonium for rapid sequence induction of general anaesthesia for caesarean section: influence on neonatal outcomes

M Kosinová, P Stourac, M Adamus, D Seidlová… - International journal of …, 2017 - Elsevier
Background In a previous study we compared rocuronium and suxamethonium for rapid-
sequence induction of general anaesthesia for caesarean section and found no difference in …

Association of anesthesia type with prolonged postoperative intubation in neonates undergoing inguinal hernia repair

A Lamoshi, J Lerman, J Dughayli, V Elberson… - Journal of …, 2021 - nature.com
Purpose The purpose of this study is to determine factors associated with prolonged
intubation after inguinal herniorrhaphy in neonates. Methods Retrospective, single institution …

Sugammadex: Applications in pediatric critical care

JD Tobias - Journal of Pediatric Intensive Care, 2020 - thieme-connect.com
Sugammadex is a novel pharmacologic agent, which reverses neuromuscular blockade with
a mechanism that differs from acetylcholinesterase inhibitors such as neostigmine. There is …

Management of neuromuscular block in pediatric patients—safety implications

YM Cha, DJ Faulk - Current Anesthesiology Reports, 2022 - Springer
Abstract Purpose of Review We summarize the current status of neuromuscular blockade
monitoring and reversal strategies in children, and the gaps that exist in our knowledge and …

Emergency sugammadex reversal in an 850-G premature infant: a case report

PN Efune, G Alex, SD Mehta - The Journal of Pediatric …, 2020 - meridian.allenpress.com
Sugammadex is a novel reversal agent for the neuromuscular blocking agents rocuronium
and vecuronium; it has been shown to rapidly and completely reverse neuromuscular …

The role of sugammadex in symptomatic transient neonatal myasthenia gravis: A case report

JE Rubin, RJ Ramamurthi - A&A Practice, 2017 - journals.lww.com
We describe the case of a 3-week-old boy with pyloric stenosis who presented for
laparoscopic pyloromyotomy in the setting of symptomatic transient neonatal myasthenia …

[PDF][PDF] Retrospective Study of the Restoration of Neuromuscular Blockage with Sugammadex in Newborns Who Used Rocuronium.

HŞ Türk, L Kılınc, P Sayın… - Southern Clinics of Istanbul …, 2019 - jag.journalagent.com
Objective: The aim of the present study was to discuss the effects of antagonism of
neuromuscular blockade with sugammadex on extubation success and residual curarization …

" Off-label use" of sugammadex in a neonate.

F Wunderer, N L'Allemand… - Anaesthesiologie & …, 2021 - search.ebscohost.com
Während sich über die letzte Dekade der Gebrauch des spezifischen Antidots Sugammadex
zur Reversierung des nichtdepolarisierenden Muskelrelaxans Rocuronium bei …